Vital Signs Monitoring
Showing 9976 - 10000 of >10,000
Pulmonary Disease, Chronic Obstructive, Enterovirus Infections, Rhinovirus Trial in Uppsala (CUR-N399, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- +2 more
- CUR-N399
- Placebo
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Mar 22, 2022
Traumatic Brain Injury, Vascular Accident, Brain Trial in New York (Brain Fitness Program, Weekly Telephone Contact)
Completed
- Traumatic Brain Injury
- Vascular Accident, Brain
- Brain Fitness Program
- Weekly Telephone Contact
-
New York, New YorkNYU Langone Medical Center, Rusk Institute for Rehabilitation
Mar 29, 2021
Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)
Not yet recruiting
- Digestive Health
- +2 more
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Placebo
-
Montréal, Quebec, CanadaMcGill University, Currie Gymnasium (Exercise Metabolism and Nut
Jul 21, 2023
Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 19, 2022
Psoriasis, Aging, Epigenetic Disorder Trial in Providence (TILDRAKIZUMAB)
Recruiting
- Psoriasis
- +3 more
- TILDRAKIZUMAB
-
Providence, Rhode IslandClinical Trials Center for Skin Diseases: Rhode Island Hospital,
Apr 9, 2022
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Recruiting
- Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 17, 2022
Merkel Cell Carcinoma Trial in Worldwide (domatinostat in combination with avelumab)
Active, not recruiting
- Merkel Cell Carcinoma
- domatinostat in combination with avelumab
-
Leuven, Belgium
- +21 more
Mar 16, 2022
Opioid-use Disorder Trial in United States (CAM2038, Buprenorphine Sublingual Product)
Recruiting
- Opioid-use Disorder
- CAM2038
- Buprenorphine Sublingual Product
-
Phoenix, Arizona
- +34 more
Aug 31, 2021
Cardiac Sarcoidosis Trial in Birmingham (hybrid PET/MRI)
Suspended
- Cardiac Sarcoidosis
- hybrid PET/MRI
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 4, 2021
Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy Trial in Benevento (Left ventricular contractile reserve SE,
Recruiting
- Coronary Artery Disease
- +6 more
- Left ventricular contractile reserve SE
- +6 more
-
Benevento, ItalyFatebenefratelli Hospital
Oct 4, 2021
"De Novo" Atrial Fibrillation in Heart Failure: Incidence;
Recruiting
- Atrial Fibrillation
- Heart Failure
- Linq II implantable cardiac monitor
-
Santiago De Compostela, A Coruña, SpainMoises Rodriguez Mañero
Feb 11, 2021
Depressive Disorder Trial in Melbourne (Lithium, Placebo)
Active, not recruiting
- Depressive Disorder
- Lithium
- Placebo
-
Melbourne, Victoria, AustraliaHospital
Jun 20, 2023
Healthy Trial in New Haven (Single dose of PF-07104091 as Tablet Formulation A (Treatment A), Single dose of PF-07104091 as
Recruiting
- Healthy
- Single dose of PF-07104091 as Tablet Formulation A (Treatment A)
- +4 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 21, 2022
Hearing Loss, Cochlear, Neurinoma of the Acoustic Nerve Trial in France (Neuristim, Cochlear implant)
Completed
- Hearing Loss, Cochlear
- Neurinoma of the Acoustic Nerve
- Neuristim
- Cochlear implant
-
Bordeaux, France
- +3 more
Oct 13, 2021
NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +5 more
- CART-TnMUC1
- +2 more
-
Phoenix, Arizona
- +9 more
Jul 18, 2022
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Bronchopulmonary Dysplasia Trial in Ottawa (Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells)
Not yet recruiting
- Bronchopulmonary Dysplasia
- Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells
-
Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
Oct 7, 2022
Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed
- Guillain-Barre Syndrome
- plasmapheresis
-
Assuit, Assiut, EgyptAssiut university
Dec 7, 2022
COVID-19 on Myocardial Function and Exercise Capacity
Recruiting
- Covid19
- Heart Failure
- Diagnostic tests
-
Łódź, Polska, PolandHeart Failure Unit; Department of Cardiology and Congenital Dise
May 6, 2022
Prematurity; Extreme, Feeding Patterns, Ventilator Lung; Newborn Trial in Chicago (Method of feeding)
Recruiting
- Prematurity; Extreme
- +2 more
- Method of feeding
-
Chicago, IllinoisCook County Helath
Apr 11, 2023
Crohn Disease, Ulcerative Colitis Trial in Bonheiden, Gent (infliximab therapeutic drug monitoring)
Completed
- Crohn Disease
- Ulcerative Colitis
- infliximab therapeutic drug monitoring
-
Bonheiden, Belgium
- +1 more
Jul 29, 2021
Anti-SARS-CoV-2 and Encapsulated Vaccination Thalassemic and
Recruiting
- SARS-CoV-2 Infection, Thalasemmie, SCD
-
Torino, TO, Italy
- +8 more
Feb 1, 2022